Synovus Financial’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,068
| Closed | -$246K | – | 925 |
|
|
2024
Q2 | $246K | Sell |
2,068
-371
| -15% | -$44.1K | ﹤0.01% | 775 |
|
|
2024
Q1 | $260K | Sell |
2,439
-455
| -16% | -$48.5K | ﹤0.01% | 767 |
|
|
2023
Q4 | $288K | Buy |
+2,894
| New | +$288K | ﹤0.01% | 726 |
|
|
2023
Q1 | – | Sell |
-1,235
| Closed | -$222K | – | 862 |
|
|
2022
Q4 | $222K | Sell |
1,235
-2,805
| -69% | -$504K | ﹤0.01% | 791 |
|
|
2022
Q3 | $476K | Sell |
4,040
-230
| -5% | -$27.1K | 0.01% | 591 |
|
|
2022
Q2 | $612K | Buy |
4,270
+221
| +5% | +$31.7K | 0.01% | 536 |
|
|
2022
Q1 | $704K | Buy |
4,049
+300
| +8% | +$52.2K | 0.01% | 512 |
|
|
2021
Q4 | $959K | Sell |
3,749
-86
| -2% | -$22K | 0.01% | 467 |
|
|
2021
Q3 | $1.48M | Sell |
3,835
-235
| -6% | -$90.8K | 0.02% | 359 |
|
|
2021
Q2 | $950K | Sell |
4,070
-994
| -20% | -$232K | 0.01% | 444 |
|
|
2021
Q1 | $664K | Buy |
5,064
+786
| +18% | +$103K | 0.01% | 489 |
|
|
2020
Q4 | $444K | Buy |
4,278
+819
| +24% | +$85K | 0.01% | 570 |
|
|
2020
Q3 | $244K | Buy |
3,459
+177
| +5% | +$12.5K | ﹤0.01% | 642 |
|
|
2020
Q2 | $210K | Buy |
3,282
+3,082
| +1,541% | +$197K | ﹤0.01% | 638 |
|
|
2020
Q1 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 1711 |
|